FDA Inspection 833293 — Hologic, Inc.

Hologic, Inc. — FEI 2024800

The FDA completed an inspection of Hologic, Inc. on May 24, 2013 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 24, 2013
Fiscal Year
2013
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Diego, CA (United States)